← SynDRA
HARRINGTONINE
SynDRA canonical compound SYN0002326 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Mechanism of action | protein synthesis inhibitor |
Mechanisms of action (all sources)
- protein synthesis inhibitor
Cross-references
Synonyms
- Harringtonin
- 2'R-Harringtonine
- NSC 124147
- CHEBI:5626
- NSC124147
- Alkaloid C from cephalotaxus
- 088662H40F
- harringtonine(8ci)
- 1-((1S,3aR,14bS)-2-methoxy-1,5,6,8,9,14b-hexahydro-4H-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepin-1-yl) 4-methyl (R)-2-hydroxy-2-(3-hydroxy-3-methylbutyl)succinate
- Cephalotaxine, 4-methyl (2R)-2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate (ester)
- UNII-088662H40F
- ZJ-H
- SCHEMBL138806
- HARRINGTONINE [WHO-DD]
- CHEMBL433257
- Cephalotaxine, 4-methyl 2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate (ester)
- DTXSID501016801
- HY-N0862
- BDBM50480315
- MFCD28978177
- s9063
- ZINC29412110
- CCG-269921
- CS-3909
- AS-56357
- NCI60_000568
- TRANS-2-BUTENE-1,4-DICARBOXYLICACID
- Q27106830
- Cephalotaxine,3-[4-methyl (2R)-2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate]
- 1-O-[(2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl] 4-O-methyl (2R)-2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate
- Cephalotaxine, 4-methyl-, 2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate (ester), (3(R))-
- Cephalotaxine, 4-methyl-2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate (ester), (3(R))-
- AKOS037514685
- 833H852
- 1-O-(4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl) 4-O-methyl 2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate
- CHEMBL175608
- BCP04090
- AKOS030254757
Look up HARRINGTONINE in the interactive SynDRA portal →